Skip to content

Evaluation of ZestiVits in Children and Adults on a Ketogenic or Restricted Therapeutic Diet

A Study to Evaluate the Acceptability of ZestiVits; a New Vitamin, Mineral and Trace Element Supplement for Those Aged 11 and Over on a Ketogenic or Restricted Diet With Regard to Product Tolerance, Palatability and Compliance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02825758
Acronym
ZestiVits
Enrollment
15
Registered
2016-07-07
Start date
2017-02-17
Completion date
2018-08-31
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deficiency of Micronutrients

Keywords

Micronutrients, restricted, ketogenic, diet, acceptability

Brief summary

A study to evaluate the acceptability of ZestiVits; a new vitamin, mineral and trace element supplement for children aged 11 years and over and adults on a ketogenic or restricted therapeutic diet with regard to product tolerance, palatability and compliance.

Detailed description

To evaluate the gastrointestinal tolerance, palatability and compliance of ZestiVits in a seven-day period for 15 subjects aged 11 years and over following a ketogenic or restricted therapeutic diet. * Qualitative assessments from subject questionnaires that allow evaluation of the acceptability and ease of use of the study product. * Collection of daily data about the gastro-intestinal tolerance of the study product. * Collection of daily data about compliance with the study product i.e. actual versus prescribed intake. * Improve quality of life by increasing range of products available for use in a ketogenic or restricted therapeutic diet.

Interventions

DIETARY_SUPPLEMENTZestiVits

The study product is a low-carbohydrate, orange flavour, vitamin, mineral and trace element (micronutrient) supplement for use in ketogenic and restricted therapeutic diets, for children aged from 11 years of age and adults. The recommended dosage of the study product for each subject will be determined and prescribed by a dietitian. This will be based on individual requirements for micronutrient supplementation.

Sponsors

Vitaflo International, Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of condition requiring a ketogenic or restrictive therapeutic diet 2. On a ketogenic or restricted therapeutic diet with good compliance 3. Aged 11 years and over 4. Has a requirement for a micronutrient supplement 5. Written informed consent by subject or parent/carer

Exclusion criteria

1. Participants aged less than 11 years 2. Use of additional micronutrient supplements during the study period unless clinically indicated and prescribed by the investigator (must be recorded in patient case record file)

Design outcomes

Primary

MeasureTime frameDescription
Palatability via qualitative assessments from a subject questionnaire7 daysQualitative outcome measures will be described in a narrative summarising the study outcomes
Gastrointestinal tolerance via qualitative assessments from a subject questionnaire7 daysQualitative outcome measures will be described in a narrative summarising the study outcomes
Patient compliance via qualitative assessments from a subject questionnaire7 daysQualitative outcome measures will be described in a narrative summarising the study outcomes
Ease of use of product via qualitative assessments from a subject questionnaire7 daysQualitative outcome measures will be described in a narrative summarising the study outcomes

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026